Case Page

 

Case Status:    ONGOING    
On or around 09/20/2017 (Ongoing date of last review)

Filing Date: February 13, 2017

According to the law firm press release, USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease.

On August 16, 2010, USANA announced that it had acquired BabyCare Ltd. (“BabyCare”), a China-based manufacturing company that develops and sells nutritional products primarily for infants. Over the next six years, USANA steadily expanded BabyCare’s market presence in China. In February 2013, the Company announced that it had received official government approval from the Ministry of Commerce People’s Republic of China (“MOFCOM”) for direct selling activities in the provinces of Jiangsu and Shaanxi, and the municipality of Tianjin. In May 2016, USANA announced MOFCOM approval for direct selling activities in the provinces of Liaoning, Shandong, Shanxi, Sichuan, and Guangdong, as well as the municipalities of Dalian, Qingdao, and Shenzhen.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company’s BabyCare subsidiary had engaged in improper reimbursement practices in China; (ii) these practices constituted violations of the Foreign Corrupt Practices Act (“FCPA”); (iii) as such, the Company’s China revenues were in part the product of unlawful conduct and unlikely to be sustainable; (iv) the foregoing conduct, when it became known, was likely to subject the Company to significant regulatory scrutiny; and (v) as a result of the foregoing, USANA’s public statements were materially false and misleading at all relevant times.

COMPANY INFORMATION:

Sector: Healthcare
Industry: Biotechnology & Drugs
Headquarters: United States

SECURITIES INFORMATION:

Ticker Symbol: USNA
Company Market: NASDAQ
Market Status: Public (Listed)

About the Company & Securities Data


"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.

In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
COURT: D. Utah
DOCKET #: 17-CV-00106
JUDGE: Hon. Brooke C. Wells
DATE FILED: 02/13/2017
CLASS PERIOD START: 03/14/2014
CLASS PERIOD END: 02/07/2017
PLAINTIFF FIRMS NAMED IN COMPLAINT:
  1. Christensen Young & Associates
    9980 South 300 West, Suite 200, Christensen Young & Associates, UT 84070
    (801) 285-7491 (888) 569-2786 ·
  2. Goldberg Law PC (Los Angeles)
    1999 Avenue of the Stars, Goldberg Law PC (Los Angeles), CA 90067
    1-800-977-7401 1-800-536-0065 ·
  3. Pomerantz LLP (New York)
    600 Third Avenue, Pomerantz LLP (New York), NY 10016
    212.661.1100 212.661.8665 · info@pomerantzlaw.com/
No Document Title Filing Date
COURT: D. Utah
DOCKET #: 17-CV-00106
JUDGE: Hon. Brooke C. Wells
DATE FILED: 08/04/2017
CLASS PERIOD START: 03/14/2014
CLASS PERIOD END: 02/07/2017
PLAINTIFF FIRMS NAMED IN COMPLAINT:
  1. Christensen Young & Associates
    9980 South 300 West, Suite 200, Christensen Young & Associates, UT 84070
    (801) 285-7491 (888) 569-2786 ·
  2. Goldberg Law PC (Los Angeles)
    1999 Avenue of the Stars, Goldberg Law PC (Los Angeles), CA 90067
    1-800-977-7401 1-800-536-0065 ·
  3. Pomerantz LLP (Chicago)
    10 South LaSalle Street, Suite 3505 , Pomerantz LLP (Chicago), IL 60603
    312-377-1181 312-377-1184 ·
No Document Title Filing Date